Institutional investors purchased a net $1.5 million shares of CVM during the quarter ended December 2015. This may signal that the smart money is gaining interest in this company as the 7.13% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
INVESTMENT CENTERS OF AMERICA, I... Bought 20.4 Thousand shares of CEL-SCI Corp
CREATIVE PLANNING, INC. Sold 300.00 shares of CEL-SCI Corp